Announced
Woods Investment to acquire Taiwan Liposome from PAG.
Synopsis
Woods Investment to acquire Taiwan Liposome, a clinical-stage specialty pharmaceutical company, from PAG, an alternative investment firm.
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.